ABOUT THIS PROJECT
Dr Altman is considered among the top ten to fifteen experts in menopausal medicine in the United States. Dr. Altman has been involved with the development of Addyi, as an advisor, over the past six years, first with Boehringer-Ingelheim, where the drug was developed, and then with Sprout Pharmaceuticals, a company formed specifically to bring Addyi through FDA approval and onto the market.
